| Chiusolo, Patrizia |
| Recruiting | 3 | 414 | Europe | Gemtuzumab Ozogamicin | Gruppo Italiano Malattie EMatologiche dell'Adulto, Fondazione GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Franco Mandelli Onlus, Pfizer S.R.L. | Acute Myeloid Leukemia | 04/25 | 04/27 | | |
| Recruiting | 3 | 322 | Europe, Canada, US | Crenolanib, Crenolanib besylate, Cytarabine, Mitoxantrone, Placebo Oral Tablet, Fludarabine, Idarubicin, G-CSF | Arog Pharmaceuticals, Inc. | Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations | 10/24 | 10/24 | | |
GITMO-PHYLOS, NCT03270748: Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies |
|
|
| Completed | 2 | 78 | Europe | GvHD prophylaxis | Gruppo Italiano Trapianto di Midollo Osseo | Myeloid Malignancies | 11/22 | 11/22 | | |
| Active, not recruiting | 2 | 120 | Europe | Pentaglobin | Gruppo Italiano Trapianto di Midollo Osseo | Septic Shock | 05/24 | 05/25 | | |
| Recruiting | 2 | 32 | Europe | Ponatinib | Gruppo Italiano Malattie EMatologiche dell'Adulto, Incyte Biosciences International Sàrl, Docteur-Yersin 12, 1110 Morges, Switzerland, FONDAZIONE GIMEMA | Chemotherapy, Leukemia, Acute Lymphoblastic | 02/25 | 07/28 | | |
| Recruiting | 1/2 | 413 | Europe, Canada, US, RoW | revumenib, SNDX-5613, cobicistat | Syndax Pharmaceuticals, Syndax Pharmaceuticals, Inc | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia of Ambiguous Lineage | 12/27 | 12/27 | | |
|
|
|
|
|
|
|
|
|
| Recruiting | N/A | 140 | Europe | Determination of HCMV DNA in plasma after DNAse digestion., Determination of HCMV DNA in blood or plasma. | Fondazione IRCCS Policlinico San Matteo di Pavia, Ministero della Salute, Italy | Cytomegalovirus Infections, Cytomegalovirus Viremia, Hematopoietic Stem Cell Transplantation | 06/25 | 03/26 | | |
COmPACt, NCT03802773: Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide ( Study) |
|
|
| Recruiting | N/A | 10 | Europe | CB transplantation, Myeloablative conditioning and post-transplant cyclophosphamide | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Cord Blood Transplantation, Hematological Malignancies | 01/23 | 12/23 | | |
| Recruiting | N/A | 4000 | Europe | Registration into the STREAM platform | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori, Hospital Vall d'Hebron, Cyprus Institute of Neurology and Genetics, European LeukemiaNet, Fundacion Para La Investigacion Hospital La Fe, Ostedusche Hematology and Oncology Study Group, Ospedale Pediatrico Bambin Gesù, Czech Lymphoma Study Group, Charite University, Berlin, Germany, Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León, University of Bologna, Hannover Medical School, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Toscana Life Sciences Sviluppo s.r.l., Lithuanian University of Health Sciences, Gruppo Italiano Malattie EMatologiche dell'Adulto, Time.Lex | Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory | 07/32 | 07/32 | | |
| Not yet recruiting | N/A | 300 | Europe | Blood cells classification | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Blood Cancer | 09/25 | 09/25 | | |
| Recruiting | N/A | 150 | Europe, RoW | No Intervention | Takeda | Cytomegalovirus (CMV) | 04/25 | 04/25 | | |
NCT03751917: Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia |
|
|
| Recruiting | N/A | 100 | Europe | Arsenic Trioxide, ATRA+ATO | Gruppo Italiano Malattie EMatologiche dell'Adulto | Acute Promyelocytic Leukemia | 12/24 | 12/24 | | |
INTHEMA, NCT04298892: Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies |
|
|
| Recruiting | N/A | 2000 | Europe | clinical data and sample collection | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori, Azienda Unità Sanitaria Locale della Romagna | Haematologic Disease, Haematological Malignancy | 02/25 | 02/25 | | |
| Tolomelli, Giulia |
| Recruiting | 3 | 550 | Europe, Canada, US, RoW | Tamibarotene, SY-1425, Placebo, Azacitidine | Syros Pharmaceuticals | Myelodysplastic Syndromes | 11/24 | 02/29 | | |
NCT04460950: Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms |
|
|
| Recruiting | N/A | 237 | Europe | | Gruppo Italiano Malattie EMatologiche dell'Adulto | Acute Myeloid Leukemia, Familial Acute Myeloid Leukemia, Myelodysplastic Syndromes | 03/25 | 03/25 | | |
INTHEMA, NCT04298892: Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies |
|
|
| Recruiting | N/A | 2000 | Europe | clinical data and sample collection | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori, Azienda Unità Sanitaria Locale della Romagna | Haematologic Disease, Haematological Malignancy | 02/25 | 02/25 | | |
